Helixgate

Helixgate

Uncategorized

Sanofi defends Garijo appointment, says it is ‘fully committed’ to immunology

Published

on

Sanofi’s first-quarter earnings call with the media on Thursday was an exercise in redirecting the narrative before its new CEO steps in next week.

CFO François-Xavier Roger defended the company’s appointment of Merck KGaA’s Belén …

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

GSK cuts deal with Sino to broaden reach of hepatitis B drug

The marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and could speed access to a therapy called bepirovirsen that’s important to its future.

Read More

Published

on

The marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and could speed access to a therapy called bepirovirsen that’s important to its future.

Read More

Continue Reading

Uncategorized

Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise push

Published

on

Daiichi Sankyo is betting on its oncology franchise to push it past 3 trillion Japanese yen ($19 billion) in 2030 revenues.

The drugmaker published a new five-year business plan on Monday …

Continue Reading

Uncategorized

New home for Novo’s Parkinson’s cell therapy; GSK turns to China for hep B drug

Published

on

Plus, label expansions for two drugs targeting rare diseases, and Genmab scraps a Phase 1 cancer trial:

🧠 Novo’s Parkinson’s cell therapy finds a biotech home: Novo Nordisk has found a home for an early-stage …

Continue Reading
Advertisement

Trending